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Effects of NO2 on Chronic Bronchitics
by G. von Nieding* and H. M. Wagnert
The acute influence ofNO2 on mechanics ofbreathing and respiratory gas exchange was investigated in
a total of 111 subjects, aged 25 to 74 years, with chronic nonspecific lung disease (CNSLD). They breathed
NO2-air mixtures containing 0.5 to 8.0 ppm NO2 for up to 15 to 60 min. Additionally in nine subjects the
protective action of atropine, meclastine, and orciprenaline was investigated.
While the alveolar P02 remained nearly constant during inhalation of 5 and 4 ppm NO2, a significant
decrease of the arterial P02 and a corresponding increase of the arterial to alveolar P02 gradients
occurred. Inhalation of 2 ppm NO2 had not such an effect.
Inhalation of NO2 at concentrations down to 1.5 ppm resulted in a significant increase of airway
resistance. Lower concentrations had no significant effect.
Prolongation ofthe exposure period from 15 to 60 min at a NO2 concentration of5 ppm did not result in
a more pronounced disturbance of the respiratory gas exchange for oxygen beyond the extent observed
after exposure to 5 ppm NO2 for 15 min.
Meclastine, in comparison with orciprenaline and atropine, showed a pronounced protective effect on
the negative impact of NO2 on respiratory gas exchange and airway resistance.
It is concluded that NO2 may act by release of histamine, causing a bronchiolar, alveolar, and intersti-
tial edema, thus differing from irritant air pollutants like SO2, where reflex bronchoconstriction causes in
some bronchitics dramatic increases of airway resistance at similar low concentrations.
Introduction
Chronic nonspecific lung diseases are an impor-
tant cause of disability and untimely death in all
industrialized countries; this seems to be related to
occupational and environmental pollution.
Existing data from experimental animal studies
with oxidizing air pollutants like NO2 have shown
that chronic inhalation leads to serious morphologi-
cal lesions especially in the lung periphery (1)
whereas SO2, for example, does not seem to have
such effects or only at higher concentrations (2, 3).
Human experimental exposure studies are re-
stricted to short-term exposures in the range of
MAK concentrations and below or of concentra-
tions observed in ambient air because of ethical
considerations, and it is discussed whether such ex-
periments can be performed on the more suscepti-
ble subjects like asthmatics or bronchitics who need
special protection by safe standards. [The German
MAK value (maximal allowable concentration for
occupational exposure) mentioned in this paper cor-
responds to the TLV, i.e., 5 ppm for NO2.]
Although there is a quite general agreement that
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changes of lung function will occur when inhaling
this pollutant at concentrations equal to or exceed-
ing MAK values, some points request further
examination, namely, determination of the concen-
tration range where first changes of pulmonary
function are to be observed ("no-effect level");
clarification whether changes are caused by reflec-
tory bronchoconstriction or effected by mediators
like histamine; estimation from the results of these
acute experiments the possibility of a risk of the
development of chronic respiratory disease.
It has been the objective of the studies described
here (4, 5) to support to the clarification of some of
the aspects mentioned above. For this purpose, the
acute influence of NO2 on mechanics of breathing
and respiratory gas exchange was investigated in
subjects with chronic, nonspecific lung disease
(CNSLD). They breathed N02-air mixtures from
gas tight bags containing 0.5 to 8.0 ppm NO2 for up
to 5 and up to 60 min. Additionally in nine subjects
the protective action of atropine, meclastine, and
orciprenaline was investigated.
Methods and Subjects
A total of 116 patients, aged 25 to 74 years, suf-
fering from chronic, nonspecific lung disease were
April 1979 137investigated. These patients were admitted to the
hospital because ofan exacerbation oftheir disease.
During the time of investigation their status had
bettered and they did not suffer from severe airway
obstruction or hypoxemia.
Lung function parameters of interest were those
for the respiratory gas exchange for oxygen and
carbon dioxide (PaO2, PA02, PaCO2, PAC02, and
pHa), airway resistance (R&W) measured as total air-
way resistance from the extreme pressure points of
the pressure/flow diagram (6) and thoracic gas vol-
ume (TGV) to indicate functional residual capacity
(FRC) where Rt was measured. Phase shift caused
by the Fleisch pneumotachograph when breathing
at higher frequencies was avoided by having the
subjects breathe at normal frequencies. Mea-
surements of Rt has proved to be a sensitive indi-
cator for changes in lung function associated with
gaseous pollutants at low concentrations (7-10).
(Dynamic manoeuvres like FEV, or V50 probably
are less suited for such investigations because they
themselves-especially in bronchitics and
asthmatics-may influence the results.)
Continuous measurement of PA02 and PAC02
(as measured in bypass at the mouthpiece) was used
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for control of the steady state necessary for arterial
PO2 and PCO2 analysis and for calculation of the
alveolar-to-arterial P02 and PCO2 gradients AaDO2
and aADC02. The blood samples were taken from
hyperemized ear lobe blood in sitting position.
Hyperemized blood from the ear lobe was consid-
ered to be representative for arterial blood accord-
ing to preparatory studies comparing P02 in blood
simultaneously obtained by arterial puncture and in
micro samples from the hyperemized ear lobe (11).
The usability of this method was further approved
by more recent investigations of P02 measurement
via the skin by means of a continuously measuring
platinum electrode, where the P02 follows im-
mediately the changes in alveolar P02 thus giving
exact the features of respiratory gas exchange (16).
The instruments used were a respiratory mass
spectrometer (Varian MAT), platinum and glass
electrodes (Eschweiler), and a constant volume
body plethysmograph (own construction analogous
to the Siemens body box with electronic compensa-
tion of differences in temperature and water vapor
between inhaled and expired air allowing breathing
at normal frequencies (12).
Measurement of lung function parameters was
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FIGURE 1. Mean values and standard deviations of PAO2 and PaO2 (A) before, (B) at the end, and (C) after inhalation of5, 4, and 2 ppm
NO2 for 15 min.
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FIGURE 2. Mean values and standard deviations of alveolar and
arterial oxygen partial pressures (PAO2 and PaO2) and the
alveolar to arterial oxygen gradients (AaDO2) before, during,
and after a 60 min exposure to NO2 concentrations of 5 ppm
(n = 14).
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FIGURE 4. Dependence of the increase in relative airway resis-
tance (Rt) upon the concentration (r = 0.542): (*) smokers;
(0) nonsmokers.
made at the end of the prephase, after exposure to
the different NO2-air mixtures (1.0-8.0 ppm) for
different times (up to 5 and up to 60 min) and within
2 1 hr after termination of exposure.
The protective action of atropine (0.75 mg SC),
meclastine (2.68 mg IV) and orciprenaline (1.5 mg
by inhalation) was tested as described previously
(5).
Analysis of NO2 was made by using the col-
orimetric Saltzman method (13).
The statistical evaluation was made with the aid
of Wilcoxon's ranking method of pair differences
(14, 15) where the null hypothesis (= no effect) was
subjected to a one-sided test.
Results
L1.0ppm 1.1-1.5ppm 1.6-2.Oppm 2.1- 2.5 ppm 2.5ppm
While the alveolar P02 remained nearly constant
during inhalation of 5 and 4 ppm NO2 (15 min), a
significant decrease of the arterial P02 and a corre-
sponding increase of the arterial to alveolar P02
gradients occurred. Inhalation of2 ppm NO2 had no
5011 1- - 1 -such effect (Fig. 1).
A prolongation ofthe exposure period from 15 to
60 min at a NO2 concentration of 5 ppm did not
1_ 477 5.63 3955. 5.84 result in a more pronounced disturbance ofthe res-
--L.. :-piratory gas exchange for oxygen beyond the extent
p.O.1 p.01 0.1.p3.QO5 P.0.01 pOQll observed after exposure to 5 ppm NO2 for 15 min
4 10 15 10 14 (Fig. 2).
3. Increase in total airway resistance (R,) (mean values Inhalation of NO2 concentrations down to 1.5
itandard deviations) before and after inhalation ofNO2at ppm (30 breaths 5 min) resulted in a significant
rent concentrations (initial value = 100%). increase of airway resistance. Lower concentra-
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FIGURE 5. Mean values and standard deviations oftotal airway resistance R, in 14 subjects with chronic bronchitis (left in each pair of
columns) before and (right) after inhalation of 5 ppm NO2 for up to 5 min without and with atropine, meclastine, orciprenaline, and
NaCI as control.
tions had no significant effect (Figs. 3 and 4).
Meclastine, when compared with orciprenaline
and atropine, showed a protective effect (Fig. 5) on
the negative impact of NO2 on respiratory gas ex-
change (30 breaths 5 min) and airway resistance.
Discussion
The results indicate that short-term exposures to
NO2 may have discrete effects on human lung func-
tion. At NO2 concentrations in the MAK range, the
effect on respiratory gas exchange is relatively uni-
form: the consistent PaO2 decrease of about 8 mm
Hg indicates that irritant gases like NO2 in low con-
centrations cause a uniform reaction in the lung.
This is supported by a similarly uniform increase of
airway resistance even in previously compromised
subjects, where, corresponding to healthy subjects
(9, 10), Rai,c increases between 0.5 and 2.0 cm H20/
(liter sec) may generally be observed.
After acute exposure to NO2 airway resistance
has shown to increase at concentrations above 1.5
ppm. In healthy subjects a similar increase ofR,,,,. at
NO2 concentrations of 2.5 ppm was shown (7).
There is some indication that histamine release
might play a role in triggering the effects on lung
function observed after inhalation of NO2. Thomas
(17) has shown degranulation of mast cells in rat
lung tissue after acute exposure to low NO2 con-
centrations (0.5-1.0 ppm). In human subjects ex-
posed to 5-8 ppm NO2 for up to 5 min, a marked
protective action of a histamine-suppressing agent
(meclastine) was demonstrated; atropine or 3-
stimulating agents did not have such an effect (5).
However, in preliminary studies with quantitative
estimation of the histamine content of plasma be-
fore, during, and after inhalation of a combination
of NO2, 03, and SO2 for 2 hr at MAK concentra-
tions, a well defined histamine release was demon-
strated only in one half of the subjects (18).
As mentioned above, the experimental lung func-
tion studies in humans demonstrate that the func-
tional response to the inhalation of NO2 is quite
similar in all subjects. Additionally, these very uni-
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140form and discrete changes, especially those of the
airway resistance, suggest that the observed effects
are probably due to formation ofmicroedema ofthe
bronchial or interstitial epithelium by histamine lib-
eration and not by reflectory bronchoconstriction.
However, histamine could also directly increase the
tonus of the peripheral muscles, not being influ-
enced by the nervus vagus, with disturbance of the
ventilation/perfusion ratios and consecutive de-
crease of PaO2 (/9).
Reflectory bronchoconstriction after vagal
stimulation probably would lead to a more in-
homogeneous reaction of the bronchial tree with
less uniform reactions of airway resistance in the
different subjects. Reflex bronchoconstriction may
be true for SO2 inhalation, where the possibility ofa
vagal stimulated bronchoconstriction is discussed
(8) and where at similar low concentrations in pa-
tients with obstructive lung disease dramatic in-
creases of R,,,. are likely to occur (20). The more
pronounced increase of airway resistance after in-
halation ofNO2 alone or NO2 + S02 + O: in combi-
nation with a bronchoconstricting agent like car-
bachol or acetylcholine is probably due to an in-
creased reactivity of sensory receptors caused by
air pollutants and thus a vagal reaction (10, 21).
An estimation of the risk of the development of
chronic respiratory disease may be drawn from ex-
perimental animal studies: e.g., after short-term ex-
posure to 5 ppm NO2, aconfiguration change occurs
in lung collagen and elastin. This denaturation of
collagen and elastin was shown to be reversible
when the animals were sacrificed 24 hr after termi-
nation of exposure (22). An exposure of rabbits to
low concentrations of NO2 (0.255 ppm) for 4 hr/day
for 6 days, however, showed irreversible structural
changes in lung collagen as determined by electron
microscopy (23). Possibly owing to increased colla-
gen and elastin catabolism in the lung, the hy-
droxyproline excretion was elevated in workers
chronically exposed to NO2 levels of 0.4-2.7 ppm
(24) and in experimental animals after long-term in-
halation of concentrations slightly above 2.5 ppm
(25).
A crosslinking of collagen and elastin fibers ob-
served in animals after short-term exposure may be
an important fact in estimating part of the risk of
development ofchronic lung disease: this resembles
an accelerated aging process, as normally collagen
and elastin become macromolecules by crosslinking
in aging processes. Equally important is the obser-
vation of a delayed maturation of the rat lung in an
environment containing nitrogen dioxide (26). More
recent findings indicate that exposures to NO2 at
low concentrations will cause a significant increase
in the mortality ofmice challenged with streptococ-
cus aerosol after exposure to the pollutant. The
same effect was seen at even lower pollutant levels
when mixtures ofNO2 and 03 at concentrations fre-
quently found in ambient air were used (27, 28).
Chronic exposure to NO2 leads to morphological
changes in rats such as terminal bronchiolar hyper-
trophy, loss of cilia, desquamation of alveolar cells
and thickening of alveolar septa at NO2 concentra-
tions of 2.0 ppm this being an index for pre-
emphysematous changes in the lung (1). Addition-
ally, long-term as well as short-term exposure to
NO2 leads to changes in the alveolar cell popula-
tions; after chronic exposure to concentrations of2
ppm NO2 pneumocyte I type cells were gradually
replaced by the more cuboidal type II pneumocytes
(29-31).
Although the carcinogenic or cocarcinogenic ef-
fects of NO2 have not been proved to date, nitro-
samine formation is also a potential hazard (32, 33).
Conclusions
In considering the concentrations of NO., at
which adverse effects in humans first appear with
ambient air concentrations, there is relatively little
room for a sufficiently great "safety factor" when
considering ambient air standards for NO.,.
A number of studies based on the use of lung
function parameters as indicators for short-term
effects have demonstrated that the MAK value for
NO2 is clearly above the level at which significant
changes in lung function occur. It is concluded that
NO2 may act primarily by release of histamine,
causing bronchiolar, alveolar, and interstitial
edema, thus differing from irritant air pollutants like
SO2, where reflex bronchoconstriction is consid-
ered to cause dramatic increases of airway resis-
tance in some bronchitics at similar low concentra-
tions (20).
Increased susceptibility to infectious agents of
bronchitics and asthmatics, demonstrated in ani-
mals (26), combination with an increased irritability
of the bronchial system after short-term exposures
to NO2, as indicated by the study of Orehek et al.
(20), and adverse effects on lung function, as dis-
cussed in this paper, may be a potential hazard: this
has to be taken into consideration, when setting a
short-term standard for NO2.
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